Your browser doesn't support javascript.
loading
CAR T cells targeting tumor endothelial marker CLEC14A inhibit tumor growth.
Zhuang, Xiaodong; Maione, Federica; Robinson, Joseph; Bentley, Michael; Kaul, Baksho; Whitworth, Katharine; Jumbu, Neeraj; Jinks, Elizabeth; Bystrom, Jonas; Gabriele, Pietro; Garibaldi, Elisabetta; Delmastro, Elena; Nagy, Zsuzsanna; Gilham, David; Giraudo, Enrico; Bicknell, Roy; Lee, Steven P.
Affiliation
  • Zhuang X; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
  • Maione F; Laboratory of Transgenic Mouse Models, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy, and Department of Science and Drug Technology, University of Torino, Torino, Italy.
  • Robinson J; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
  • Bentley M; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
  • Kaul B; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
  • Whitworth K; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
  • Jumbu N; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
  • Jinks E; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
  • Bystrom J; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
  • Gabriele P; Radiation Therapy Laboratory, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.
  • Garibaldi E; Radiation Therapy Laboratory, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.
  • Delmastro E; Radiation Therapy Laboratory, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.
  • Nagy Z; Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom.
  • Gilham D; Clinical and Experimental Immunotherapy Group, University of Manchester, Manchester, United Kingdom.
  • Giraudo E; Laboratory of Transgenic Mouse Models, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy, and Department of Science and Drug Technology, University of Torino, Torino, Italy.
  • Bicknell R; Institute of Cardiovascular Science, University of Birmingham, Birmingham, United Kingdom.
  • Lee SP; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
JCI Insight ; 5(19)2020 10 02.
Article de En | MEDLINE | ID: mdl-33004686
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lymphocytes T / Molécules d'adhérence cellulaire / Immunothérapie adoptive / Carcinome pulmonaire de Lewis / Carcinome du canal pancréatique / Lectines de type C / Récepteurs chimériques pour l'antigène / Néovascularisation pathologique Limites: Animals / Female / Humans / Male Langue: En Journal: JCI Insight Année: 2020 Type de document: Article Pays d'affiliation: Royaume-Uni Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lymphocytes T / Molécules d'adhérence cellulaire / Immunothérapie adoptive / Carcinome pulmonaire de Lewis / Carcinome du canal pancréatique / Lectines de type C / Récepteurs chimériques pour l'antigène / Néovascularisation pathologique Limites: Animals / Female / Humans / Male Langue: En Journal: JCI Insight Année: 2020 Type de document: Article Pays d'affiliation: Royaume-Uni Pays de publication: États-Unis d'Amérique